Indian-made Myval and Myval Octacor were put to the test against Sapien 3 in the noninferiority trial COMPARE TAVI-1. Noninferiority was demonstrated when counting deaths, strokes, moderate or severe ...
From 2015 to 2020, the number of patients opting for valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) over redo surgical aortic valve replacement (SAVR) rose significantly, from 35.3% ...
CHICAGO, IL—Patients with asymptomatic severe aortic stenosis who are watched until symptoms develop before undergoing TAVI are a greater risk of dying, being hospitalized for heart failure (HF), or ...
People with a small aortic annulus, a part of the heart's anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular ...
Abiomed is taking certain Impella Controllers off the market due to failing circuitry. One related death has already been reported, the FDA alerted. Medtronic announced FDA approval of a redo ...
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
Balloon Rupture During Redo-TAVR Using Sapien 3 Ultra Resilia in Failed Evolut R Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback